PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
02-May-2024 Santander provides pharma manufacturer Ennogen with £30 Million credit facility for growth Santander UK
02-May-2024 Humonix Biosciences Appoints Karen Torrejon, PhD, as New Chief Executive Officer Newswire
01-May-2024 Strategic Advisory for Leading Therapeutics Innovation Inc. (SALTI) Launches as New Management Consulting Firm Newswire
01-May-2024 CARDIO inCode-Score (CIC-Score) Presentation at the European Society of Cardiology Newswire
01-May-2024 ABPI respond to proposals to change the Statutory Scheme ABPI
30-Apr-2024 Beckman Coulter Life Sciences and Watchmaker Genomics Announce Partnership Beckman Coulter Life Sciences
30-Apr-2024 Emmecell Completes Final Cell Therapy Dosing in U.S. Clinical Trial for Corneal Edema Newswire
26-Apr-2024 PharmaLink Inc. and Recall Results, Inc. Announce Strategic Partnership to Enhance Drug Safety and Recall Efficiency Newswire
26-Apr-2024 ARAMEX SCOOPS ACCOLADE AT DISTRIBUTING PHARMACEUTICALS AWARDS Aramex
26-Apr-2024 HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda HUTCHMED
26-Apr-2024 eyeDNA Therapeutics to Present 2-year Follow-up Phase I/II Data on its Investigational Gene Therapy HORA-PDE6b for Retinitis Pigmentosa at the ARVO 2024 Annual Meeting eyeDNA Therapeutics
25-Apr-2024 CliniOps Awarded Patent for an Innovative Offline/Online eSource, or Direct Data Collection (DDC) System, for Global Clinical Trials Newswire
25-Apr-2024 Phani Konduru Joins PharmaCord as Chief Information Officer Newswire
25-Apr-2024 Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2024 Heidelberg Pharma
25-Apr-2024 Cambridge Cognition spin-out Monument Therapeutics accesses £1.5m for schizophrenia clinical development Cambridge Cognition
25-Apr-2024 LifeArc launches £40M research centres that will unlock new tests, treatments and cures for people living with rare diseases LifeArc
25-Apr-2024 Mundipharma acquires all assets and rights related to REZZAYO® (rezafungin), reinforcing continued commitment to management of infectious diseases and specialty care therapeutic area Mundipharma
24-Apr-2024 ChargePoint to expand product range by investing in a dedicated multi-million-pound single-use manufacturing facility ChargePoint Technology
24-Apr-2024 nspm and eluSCIdate Have Now Joined Cactus Life Sciences Bringing With Them Extensive Rare Disease Expertise Newswire
24-Apr-2024 Cactus Life Sciences Announces the Acquisition of nspm and eluSCIdate Newswire